| |
| |
|
| Insider
Information: |
Deerfield Special Situations Fund International Lt |
| Relationship: |
Possible Members of 10... |
| City: |
Road Town, Tortola |
| State: |
D8 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
12 |
|
| Direct
Shares |
130,000 |
|
|
Indirect Shares
|
19,698,472 |
|
|
| Direct
Value |
$330,500 |
|
|
|
Indirect Value
|
$140,960,890 |
|
|
| Total
Shares |
19,828,472 |
|
|
| Total
Value |
$141,291,390 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
21
|
4
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
21
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
-21.0
|
3.0
|
| Percentage
Gain/Loss : |
 -30.4%
|
-70.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dynavax Technologies Corp |
DVAX |
Possible members of 10... |
2006-03-03 |
0 |
2006-10-04 |
2,035,137 |
Premium* |
|
|
ISTA Pharmaceuticals Inc |
ISTA |
Possible members of 10... |
2006-06-01 |
80,000 |
2006-06-01 |
2,791,863 |
Premium* |
|
|
Par Pharmaceutical Companies Inc |
PRX |
10% Owner |
2007-02-01 |
15,000 |
2007-02-01 |
2,173,177 |
Premium* |
|
|
Corautus Genetics Inc |
VEGF |
Possible Member of 10%... |
|
0 |
2007-11-06 |
1,244,708 |
Premium* |
|
|
Cyclacel Pharmaceuticals Inc |
CYCC |
10% Owner |
|
0 |
2008-11-19 |
881,743 |
Premium* |
|
|
Neurogesx Inc |
NGSX |
10% Owner |
|
0 |
2009-07-13 |
987,880 |
Premium* |
|
|
Anadys Pharmaceuticals Inc |
ANDS |
10% Owner |
2008-10-18 |
0 |
2008-10-18 |
904,903 |
Premium* |
|
|
Neurometrix Inc |
NURO |
Possible Members of 10... |
|
0 |
2010-12-14 |
781,833 |
Premium* |
|
|
Nxstage Medical, Inc. |
NXTM |
10% Owner |
2009-12-15 |
10,000 |
2009-12-15 |
3,694,836 |
Premium* |
|
|
Talon Therapeutics Inc |
TLON |
Possible Members of 10... |
|
0 |
2012-07-05 |
136,849 |
Premium* |
|
|
Fibrocell Science Inc |
FCSC |
Possible Members of 10... |
2010-08-16 |
0 |
2010-08-16 |
1,162,800 |
Premium* |
|
|
Rigel Pharmaceuticals Inc |
RIGL |
Possible Members of 10... |
2010-11-03 |
25,000 |
2010-11-03 |
2,902,743 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
148 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DVAX |
Dynavax Technologies Corp |
10% Owner |
– – • |
2006-01-31 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
3,000,000 |
|
- |
|
| ISTA |
ISTA Pharmaceuticals Inc |
10% Owner |
– – • |
2006-04-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,538,455 |
|
- |
|
| PRX |
Par Pharmaceutical Compan... |
10% Owner |
– – • |
2006-07-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,869,885 |
|
- |
|
| VEGF |
Corautus Genetics Inc |
10% Owner |
– – • |
2007-06-29 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,057,613 |
|
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
10% Owner |
– – • |
2008-03-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,126,578 |
|
- |
|
| NGSX |
Neurogesx Inc |
10% Owner |
– – • |
2008-03-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,212,517 |
|
- |
|
| NURO |
Neurometrix Inc |
10% Owner |
– – • |
2008-10-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,845,000 |
|
- |
|
| NXTM |
Nxstage Medical, Inc. |
10% Owner |
– – • |
2009-03-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,163,253 |
|
- |
|
| TLON |
Talon Therapeutics Inc |
10% Owner |
– – • |
2009-10-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
17,509,011 |
|
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
– – • |
2010-11-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,075,000 |
|
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
Possible Member of 10% Group |
– – • |
2008-11-19 |
4 |
S |
$0.24 |
$97,310 |
I/I |
(388,793) |
881,743 |
0 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
Possible Member of 10% Group |
– – • |
2008-11-18 |
4 |
S |
$0.44 |
$24,084 |
I/I |
(54,464) |
1,142,379 |
0 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
Possible Member of 10% Group |
– – • |
2008-11-13 |
4 |
S |
$0.48 |
$128,298 |
I/I |
(261,930) |
1,200,832 |
0 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
Possible Member of 10% Group |
– – • |
2008-11-14 |
4 |
S |
$0.49 |
$17,787 |
I/I |
(36,300) |
1,177,454 |
0 |
- |
|
| NURO |
Neurometrix Inc |
Possible Members of 10% Group |
– – • |
2010-12-14 |
4 |
S |
$0.50 |
$169,130 |
I/I |
(331,900) |
781,833 |
0 |
- |
|
| NURO |
Neurometrix Inc |
Possible Members of 10% Group |
– – • |
2010-11-17 |
4 |
S |
$0.53 |
$120,937 |
I/I |
(216,839) |
1,395,522 |
0 |
- |
|
| NURO |
Neurometrix Inc |
Possible Members of 10% Group |
– – • |
2010-11-18 |
4 |
S |
$0.56 |
$368,163 |
I/I |
(623,926) |
994,930 |
0 |
- |
|
| NURO |
Neurometrix Inc |
Possible Members of 10% Group |
– – • |
2010-09-16 |
4 |
S |
$0.58 |
$410,000 |
I/I |
(700,000) |
1,685,569 |
0 |
- |
|
| NURO |
Neurometrix Inc |
Possible Members of 10% Group |
– – • |
2010-09-21 |
4 |
S |
$0.58 |
$30,355 |
I/I |
(51,570) |
1,652,457 |
0 |
- |
|
| NURO |
Neurometrix Inc |
Possible Members of 10% Group |
– – • |
2010-09-22 |
4 |
S |
$0.58 |
$1 |
I/I |
(2) |
1,652,455 |
0 |
- |
|
| NURO |
Neurometrix Inc |
Possible Members of 10% Group |
– – • |
2010-09-24 |
4 |
S |
$0.58 |
$11,600 |
I/I |
(20,000) |
1,638,170 |
0 |
- |
|
| NURO |
Neurometrix Inc |
Possible Members of 10% Group |
– – • |
2010-09-27 |
4 |
S |
$0.58 |
$116 |
I/I |
(200) |
1,638,041 |
0 |
- |
|
| NURO |
Neurometrix Inc |
Possible Members of 10% Group |
– – • |
2010-11-16 |
4 |
S |
$0.58 |
$35,895 |
I/I |
(61,882) |
1,534,745 |
0 |
- |
|
| NURO |
Neurometrix Inc |
Possible Members of 10% Group |
– – • |
2010-09-23 |
4 |
S |
$0.59 |
$1,326 |
I/I |
(2,247) |
1,651,012 |
0 |
- |
|
| NURO |
Neurometrix Inc |
Possible Members of 10% Group |
– – • |
2010-10-26 |
4 |
S |
$0.59 |
$58,410 |
I/I |
(99,000) |
1,574,478 |
0 |
- |
|
148 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
